Activation of the protein kinase A increases the DNA-binding and transcriptional activity of c-Rel in T cells

Scandinavian Journal of Immunology

Volumn 43, Issue 6, 1996, Pages 640-645

  Lahdenpohja, N ^a   Henttinen, T ^a   Hurme, M ^a  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KINETICS; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029920160     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-268.x     Document Type: Article

References (29)

1. Liou H-C, Baltimore D. Regulation of the NF-κB/rel transcription factor and I-κB inhibitor system. Curr Op Cell Biol 1993;5:477-87.
2. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
3. Traenckner EB-M, Wilk S, Baeuerle PA/A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 1994;13:5433-41.
4. Grimm S, Baeuerle PA. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem J 1993;290:297-308.
5. Grilli M, Jason J-S, Lenardo MJ. NF-κB and rel - participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993;143:1-62.
6. + T lymphocytes. Science 1992;256:1452-6.
7. Doerre S, Sista P, Sun S-C, Ballard DW, Greene WC. The c-rel protooncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc Natl Acad Sci USA 1993;90:1023-7.
8. Link E, Kerr LD, Schreck R, Zabel U, Verma IM, Baeuerle PA. Purified IκB-β is inactivated upon dephosphorylation. J Biol Chem 1992;267:239-46.
9. Serkkola E, Hurme M. Activation of NF-κB by cAMP in human myeloid cells. FEBS Lett 1993;334:327-30.
10. Neumann M, Grieshammer T, Chuvpilo S et al. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 1995;14:1991-2004.
11. Naumann M, Scheidereit C. Activation of NF-κB in vivo is regulated by multible phosphorylations. EMBO J 1994;13: 4597-607.
12. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 1995;80:573-82.
13. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991;19:249.
14. Shakov AN, Collart MA, Vassalli P, Nedospasov S, Jongeneel CV. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 1990;171:35-47.
15. Molitor JA NF-κB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 1990;87:10028-32.
16. Kerr LD, Inoue J, Davis N et al. The rel-associated pp. 40 protein prevents DNA binding of Rel and NF-κB: relationship with IκB-β and regulation by phosphorylation. Genes Dev 1991;5:1464-76.
17. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc Natl Acad Sci USA 1993;90:2532-6.
18. Pimentel-Muinos FX, Manzana J, Fresno M. Biphasic control of nuclear factor-κB activation by the T cell receptor complex: role of tumour necrosis factor α. Eur J Immunol 1995;25:179-86.
19. Li C-CH, Korner M, Ferris DK, Chen E, Dai R-M, Longo DL. NF-κB/Rel family members are physically associated phosphoproteins. Biochem J 1994;303:499-506.
20. Druker BJ, Neumann M, Okuda K, Franza BR, Griffin JD. rel is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating factor treatment of human neutrophils. J Biol Chem 1994;269:5387-90.
21. Muroi M, Suzuki T. Role of protein kinase A in LPS-induced activation of NF-κB proteins of a mouse macrophage-like cell line, J774. Cell Signal 1993;5:289-98.
22. Shirakawa F, Mizel SB. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 1989;9:2424-30.
23. 2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production. Int Immunol 1994;6:523-32.
24. Chen D, Rothenburg EV. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 1994;179:931-42.
25. Venkataraman L, Burakoff SJ, Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J Exp Med 1995;181:1091-9.
26. Cohen P. Protein phosphorylation and hormone action. Proc R Soc Lond (Biol) 1988;234:115-44.
27. Rappaport RS, Dodge GR. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 1982;155:943-8.
28. Hansen SK, Guerrini L, Blasi F. Different DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor. J Biol Chem 1994;269:22230-7.
29. Perlmutter RM, Levin SD, Appleby MW, Anderson SJ, Alberola-Ila J. Regulation of lymphocyte function by protein phosphorylation. Annu Rev Immunol 1993;11:451-99.